SCHEMBL17418554

SCHEMBL17418554

CCC[N+]1(C)CCCCC1.COCCOCCOCCC(=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
LMNA P02545 3/20 0.40
KMT2A Q03164 2/20 0.40
APOBEC3A P31941 3/20 0.38
APOBEC3G Q9HC16 3/20 0.38
BBOX1 O75936 2/20 0.37
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
CDC25A P30304 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
FFAR3 O14843 2/20 0.32
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
HTT P42858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17419077 1.00 KDM4E (0.46) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418562 1.00 KDM4E (0.46) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418322 0.99 KDM4E (0.44) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418457 0.99 KDM4E (0.44) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418383 0.99 KDM4E (0.44) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418419 0.92 LMNA (0.45) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418557 0.92 LMNA (0.45) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418716 0.92 LMNA (0.45) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17418157 0.92 KDM4E (0.57) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G
SCHEMBL17419023 0.92 KDM4E (0.57) KDM4ELMNAKMT2AAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method KOEI CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD KOEI CHEMICAL COMPANY, LIMITED (JP) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD CEL, CROCC, ALG1 KDM4E 1130/4885LMNA 271/4885KMT2A 2922/4885
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method CEL, CROCC, ALG1 KDM4E 1130/4885LMNA 271/4885KMT2A 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.